Submitted by Anonymous (not verified) on 22 September 2026 - 15:45
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 26, Status: Authorised